Publications by authors named "Holly Pacenta"

Claim this Profile
L
Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel.
Lauren E Appell, Christina Baggott, Khanh Nguyen, Snehit Prabhu, Holly Pacenta

Blood Adv· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel.
Swati Naik, Subodh Selukar, Aimee C Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Holly L Pacenta

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.
Sara K Silbert, Alexander W Rankin, Chloe N Hoang, Alexandra Semchenkova, Regina M Myers, Holly L Pacenta

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of transfusion-related iron overload varies based on oncologic diagnosis and associated treatment: Retrospective analysis from a single pediatric cancer center.
Shelby Winzent-Oonk, Alyse Staley, Vida Alami, Julie Bradley, Susan Harvey, Holly Pacenta

Pediatr Blood Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediport use as an acceptable standard for CAR T cell infusion.
Maya Eylon, Snehit Prabhu, Samuel John, Maxwell J M King, Dhruv Bhatt, Holly L Pacenta

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta

EClinicalMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, Holly L Pacenta

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Heather E Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R Verneris, Holly L Pacenta

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
Liora M Schultz, Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Holly Pacenta

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly L Pacenta

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Vanessa A Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Holly Pacenta

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
Liora M Schultz, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Vanessa A Fabrizio, Christine L Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Holly Pacenta

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
Jenna Rossoff, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L Phillips

Blood· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress in the treatment of cancer in children.
Erin Butler, Kathleen Ludwig, Holly L Pacenta, Laura J Klesse, Tanya C Watt

CA Cancer J Clin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.
Holly L Pacenta, Wendy Allen-Rhoades, David Langenau, Peter J Houghton, Charles Keller

J Clin Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia.
Holly L Pacenta, Theodore W Laetsch, Samuel John

Paediatr Drugs· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma.
Holly L Pacenta, Margaret E Macy

Drug Des Devel Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells.
Meizhang Li, Cathleen J Chang, Justin D Lathia, Li Wang, Holly L Pacenta

Glia· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis